文献速递前列腺癌

根治性局部治疗在临床淋巴结阳性前列腺癌患者中作用的系统综述

A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer.
PubMed 文献 · Eur Urol Oncol · 2019-03-23

该系统综述检索Medline、Embase和Cochrane数据库,纳入1999至2018年间发表的5项非随机回顾性对照研究,比较局部治疗(放疗或根治性前列腺切除术)±雄激素剥夺治疗(ADT)与单用ADT的肿瘤学结局。总体而言,局部治疗与总生存(OS)和肿瘤特异性生存(CSS)获益相关,但证据水平低,结果需谨慎解读。

要点

  • 5项非随机回顾性研究比较局部治疗±ADT与单用ADT,其中4项比较放疗±ADT。
  • 局部治疗(放疗及总体任何形式)与OS和CSS获益相关,未见RP±ADT或RT±ADT的明确优效性。
  • 作者指出证据水平低,结果需谨慎解读。

核心结论

  • 该系统综述提示,临床淋巴结阳性前列腺癌患者接受局部治疗在OS和CSS方面均具优势,但因现有报告证据水平低,结果需谨慎解读。

研究设计与样本

  • 采用PRISMA指南推荐方法,对Medline、Embase和Cochrane数据库进行计算机文献检索,纳入1999至2018年间发表的5项非随机回顾性对照研究,行叙述性综述和偏倚风险评估。

主要发现

  • 4项研究比较放疗±ADT与单用ADT,1项研究比较任何形式局部治疗±ADT与单用ADT。
  • 总体而言,放疗以及一般而言任何形式局部治疗与单用ADT相比均与OS及CSS获益相关。
  • 未显示根治性前列腺切除术±ADT或放疗±ADT有任何明确优效性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出现有报告证据水平低,结果需谨慎解读。
  • 纳入研究均为非随机回顾性对照研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: There is uncertainty regarding the oncologic effectiveness and the survival advantage of local treatment (LT) in men with clinically lymph node-positive (cN+) prostate cancer (PCa). OBJECTIVE: To systematically review the current literature comparing oncologic outcomes associated with the use of any form of LT for PCa patients with cN+ disease. EVIDENCE ACQUISITION: A computerized bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of LT±androgen deprivation therapy (ADT) versus ADT alone. LT included both radical prostatectomy (RP) and radiotherapy (RT). Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines, we identified five nonrandomized comparative retrospective studies published between 1999 and 2018, which were eligible for inclusion in this systematic review. A narrative review and risk-of-bias assessment were performed to determine the impact of LT on recurrence-free survival, cancer-specific survival (CSS), and overall survival (OS). EVIDENCE SYNTHESIS: Four studies compared the use of RT±ADT versus ADT alone, whereas one study compared any form of LT±ADT versus ADT alone. Different statistical strategies were used in the included studies to account for baseline measured and unmeasured confounders. Overall, the use of RT and, generally speaking, any form of LT was associated with an OS as well as a CSS benefit over ADT alone, without any clear superiority shown either by RP±ADT or by RT±ADT. CONCLUSIONS: Our systematic review suggests an advantage in terms of both OS and CSS for men with cN+ PCa receiving LT. However, these results should be interpreted with caution due to the low level of evidence of available reports. PATIENT SUMMARY: We reviewed the studies that assessed the role of local treatment in men with prostate cancer and with clinical evidence of lymph node involvement at diagnosis. We found that local treatment was constantly associated with recurrence-free, cancer-specific, and overall survival benefits throughout the included studies.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Ventimiglia E, Seisen T, Abdollah F, et al. A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer. Eur Urol Oncol. 2019. PMID: 31200844. doi:10.1016/j.euo.2019.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。